YBX2P2

Across TCGA pan-cancer cohorts, YBX2P2 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated YBX2P2 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher YBX2P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated YBX2P2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

HNSC, UCS, and UVM are the cancer types where YBX2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.760	0.617	<.001	113	view →
UCS	OS	Median	II,III,IV	0.608	0.219	<.001	102	view →
UVM	DFS	Tertile	All	0.374	0.844	<.001	74	view →
LUSC	OS	Quartile	All	0.835	0.693	<.001	64	view →
KIRC	DFS	Tertile	III,IV	0.513	0.671	.010	48	view →
CHOL	DFS	Tertile	All	0.045	0.497	.029	36	view →
COAD	DFS	Tertile	All	0.424	0.548	.010	26	view →
BRCA	DFS	Median	IV	0.346	0.746	.003	22	view →
LUAD	OS	Median	All	0.514	0.228	<.001	16	view →
THYM	DFS	Median	All	0.750	0.969	.006	11	view →
LIHC	DFS	Tertile	III,IV	0.128	0.349	.015	9	view →
UCEC	DFS	Median	All	0.870	0.920	.018	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

YBX2P2–HNSC (DFS)

Open the HNSC breakdown →